Antifungal effects of synthetic human β-defensin 3-C15 peptide
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Objectives: The purpose of this ex vivo study was to compare the antifungal activity of a synthetic peptide consisting of 15 amino acids at the C-terminus of human β-defensin 3 (HBD3-C15) with calcium hydroxide (CH) and Nystatin (Nys) against Candida albicans (C. albicans) biofilm. Materials and Methods: C. albicans were grown on cover glass bottom dishes or human dentin disks for 48 hr, and then treated with HBD3-C15 (0, 12.5, 25, 50, 100, 150, 200, and 300 μg/mL), CH (100 μg/mL), and Nys (20 μg/mL) for 7 days at 37℃. On cover glass, live and dead cells in the biomass were measured by the FilmTracer Biofilm viability assay, and observed by confocal laser scanning microscopy (CLSM). On dentin, normal, diminished and ruptured cells were observed by field-emission scanning electron microscopy (FE-SEM). The results were subjected to a twotailed t-test, a one way analysis variance and a post hoc test at a significance level of p = 0.05. Results: C. albicans survival on dentin was inhibited by HBD3-C15 in a dose-dependent manner. There were fewer aggregations of C. albicans in the groups of Nys and HBD3-C15 (≥ 100 μg/mL). CLSM showed C. albicans survival was reduced by HBD3-C15 in a dose dependent manner. Nys and HBD3-C15 (≥ 100 μg/mL) showed significant fungicidal activity compared to CH group (p < 0.05). Conclusions: Synthetic HBD3-C15 peptide (≥ 100 μg/mL) and Nys exhibited significantly higher antifungal activity than CH against C. albicans by inhibiting cell survival and biofilm.
Abstract
Objectives: The purpose of this ex vivo study was to compare the antifungal activity of a synthetic peptide consisting of 15 amino acids at the C-terminus of human β-defensin 3 (HBD3-C15) with calcium hydroxide (CH) and Nystatin (Nys) against Candida albicans (C. albicans) biofilm. Materials and Methods: C. albicans were grown on cover glass bottom dishes or human dentin disks for 48 hr, and then treated with HBD3-C15 (0, 12.5, 25, 50, 100, 150, 200, and 300 μg/mL), CH (100 μg/mL), and Nys (20 μg/mL) for 7 days at 37℃. On cover glass, live and dead cells in the biomass were measured by the FilmTracer Biofilm viability assay, and observed by confocal laser scanning microscopy (CLSM). On dentin, normal, diminished and ruptured cells were observed by field-emission scanning electron microscopy (FE-SEM). The results were subjected to a twotailed t-test, a one way analysis variance and a post hoc test at a significance level of p = 0.05. Results: C. albicans survival on dentin was inhibited by HBD3-C15 in a dose-dependent manner. There were fewer aggregations of C. albicans in the groups of Nys and HBD3-C15 (≥ 100 μg/mL). CLSM showed C. albicans survival was reduced by HBD3-C15 in a dose dependent manner. Nys and HBD3-C15 (≥ 100 μg/mL) showed significant fungicidal activity compared to CH group (p < 0.05). Conclusions: Synthetic HBD3-C15 peptide (≥ 100 μg/mL) and Nys exhibited significantly higher antifungal activity than CH against C. albicans by inhibiting cell survival and biofilm.
참고문헌 (35)
- Waltimo TMT, "Clinical aspects related to endodontic yeast infections", Endod Topics, 9, pp.66~78 (2004)
- Naglik JR, "Differential expression of Candida albicans secreted aspartyl proteinase and phospholipase B genes in humans correlates with active oral and vaginal infections", J Infect Dis, 188, pp.469~479 (2003)
- Siqueira JF Jr, "Fungal infection of the radicular dentin", J Endod, 28, pp.770~773 (2002)
- Mitchell KF, "Community participation in biofilm matrix assembly and function", Proc Natl Acad Sci U S A, 112, pp.4092~4097 (2015)
- Kumamoto CA., "Candida biofilms", Curr Opin Microbiol, 5, pp.608~611 (2002)
- Mah TF, "Mechanisms of biofilm resistance to antimicrobial agents", Trends Microbiol, 9, pp.34~39 (2001)
- Sundqvist G, "Microbiologic analysis of teeth with failed endodontic treatment and the outcome of conservative retreatment", Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 85, pp.86~93 (1998)
- Nair PN, "Intraradicular bacteria and fungi in root-filled, asymptomatic human teeth with therapy-resistant periapical Lesions: a long-term light and electron microscopic follow-up study", J Endod, 16, pp.580~588 (1990)
- Byström A, "Bacteriologic evaluation of the efficacy of mechanical root canal instrumentation in endodontic therapy", Scand J Dent Res, 89, pp.321~328 (1981)
- Gupta SP, "Evaluation of antimicrobial and antifungal efficacy of inter appointment intracanal medicaments against Enterococcus and Candida albicans: an in vitro study", J Int Oral Health, 7, pp.97~102 (2015)
- Law A, "An evidence-based analysis of the antibacterial effectiveness of intracanal medicaments", J Endod, 30, pp.689~694 (2004)
- Siqueira JF Jr, "Fungi in endodontic infections", Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 97, pp.632~641 (2004)
- Rosato A, "In vitro synergic efficacy of the combination of Nystatin with the essential oils of Origanum vulgare and Pelargonium graveolens against some Candida species", Phytomedicine, 16, pp.972~975 (2009)
- Kaomongkolgit R, "Antifungal activity of alpha-mangostin against Candida albicans", J Oral Sci, 51, pp.401~406 (2009)
- Lima SM, "Antimicrobial peptide-based treatment for endodontic infections-biotechnological innovation in endodontics", Biotechnol Adv, 33, pp.203~213 (2015)
- Paris S, "Gene expression of human beta-defensins in healthy and inflamed human dental pulps", J Endod, 35, pp.520~523 (2009)
- Schibli DJ, "The solution structures of the human beta-defensins lead to a better understanding of the potent bactericidal activity of HBD3 against Staphylococcus aureus", J Biol Chem, 277, pp.8279~8289 (2002)
- Dhople V, "The human beta-defensin-3, an antibacterial peptide with multiple biological functions", Biochim Biophys Acta, 1758, pp.1499~1512 (2006)
- Lee JK, "Antimicrobial efficacy of a human beta-defensin-3 peptide using an Enterococcus faecalis dentine infection model", Int Endod J, 46, pp.406~412 (2013)
- Lee JK, "Antibacterial efficacy of a human beta-defensin-3 peptide on multispecies biofilms", J Endod, 39, pp.1625~1629 (2013)
- Krishnakumari V, "Antifungal activities of human beta-defensins HBD-1 to HBD-3and their C-terminal analogs Phd1 to Phd3", Antimicrob Agents Chemother, 53, pp.256~260 (2009)
- Hoover DM, "Antimicrobial characterization of human beta-defensin 3derivatives", Antimicrob Agents Chemother, 47, pp.2804~2809 (2003)
- Song W, "In vitro bactericidal activity of recombinant human beta-defensin-3 against pathogenic bacterial strains in human tooth root canal", Int J Antimicrob Agents, 33, pp.237~243 (2009)
- Taff HT, "Comparative analysis of Candida biofilm quantitation assays", Med Mycol, 50, pp.214~218 (2012)
- Guerreiro-Tanomaru JM, "Comparative analysis of Enterococcus faecalis biofilm formation on different substrates", J Endod, 39, pp.346~350 (2013)
- 김도현, "Antimicrobial effect of calcium hydroxide as an intracanal medicament in root canal treatment: a literature review - Part II. in vivo studies", Restorative Dentistry and Endodontics, 40(2), pp.97~103 (2015), 대한치과보존학회
- Z Mohammadi, "Antimicrobial Activity of Calcium Hydroxide in Endodontics: A Review", 전남의대학술지, 48(3), pp.133~140 (2012), 의과학연구소
- Wang JD, "Diffusion of hydrogen ion and hydroxyl ion from various sources through dentine", Int Endod J, 21, pp.17~26 (1988)
- Kinsky SC, "Nystatin binding by protoplasts and a particulate fraction of Neurospora crassa, and a basis for the selective toxicity of polyene antifungal antibiotics", Proc Natl Acad Sci U S A, 48, pp.1049~1056 (1962)
- de Kruijff BD, "Polyene antibiotic-sterol interactions in membranes of Acholeplasma laidlawii cells and lecithin liposomes. III. Molecular structure of the polyene antibiotic-cholesterol complexes", Biochim Biophys Acta, 339, pp.57~70 (1974)
- Mohammadi Z., "Systemic, prophylactic and local applications of antimicrobials in endodontics: an update review", Int Dent J, 59, pp.175~186 (2009)
- Vylkova S, "Distinct antifungal mechanisms: beta-defensins require Candida albicans Ssa1 protein, while Trk1p mediates activity of cysteine-free cationic peptides", Antimicrob Agents Chemother, 50, pp.324~331 (2006)
- Feng Z, "Human beta-defensins: differential activity against Candidal species and regulation by Candida albicans", J Dent Res, 84, pp.445~450 (2005)
- Klüver E, "Structure-activity relation of human β-defensin 3: influence of disulfide bonds and cysteine substitution on antimicrobial activity and cytotoxicity", Biochemistry, 44, pp.9804~9816 (2005)
- Maisetta G, "Activity of human β-defensin 3 alone or combined with other antimicrobial agents against oral bacteria", Antimicrob Agents Chemother, 47, pp.3349~3351 (2003)